Arginine methylation regulates the p53 response

Nature Cell Biology

Volumn 10, Issue 12, 2008, Pages 1431-1439

  Jansson, Martin ^a   Durant, Stephen T ^a   Cho, Er Chieh ^a   Sheahan, Sharon ^a   Edelmann, Mariola ^b   Kessler, Benedikt ^b   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 5; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; APOPTOSIS; ARGININE; CARRIER PROTEINS; HELA CELLS; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN METHYLTRANSFERASES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 57049087451     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1802     Document Type: Article

References (30)

1. Levine, A. J. (p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 1997).
2. Vousden, K. H. & Lu, X. Live or let die: The cell's response to p53. Nature Rev. Cancer 2, 594-604 (2002).
3. Levine, A. J., Hu, W. & Feng, Z. The P53 pathway: What questions remain to be explored? Cell Death Differ. 13, 1027-1036 (2006).
4. Coutts, A. S. & La Thangue, N. B. The p53 response: Emerging levels of co-factor complexity. Biochem. Biophys. Res. Commun. 331, 778-785 (2005).
5. Shikama, N. et al. A novel cofactor for p300 that regulates the p53 response. Mol. Cell 4, 365-376 (1999).
6. Coutts, A. S., Boulahbel, H., Graham, A. & La Thangue, N. B. Mdm2 targets the p53 transcription cofactor JMY for degradation. EMBO Rep. 8, 84-90 (2007).
7. Demonacos, C., Krstic-Demonacos, M. & La Thangue, N. B. A TPR motif cofactor contributes to p300 activity in the p53 response. Mol. Cell 8, 71-84 (2001).
8. Demonacos, C., Krstic-Demonacos, M., Smith, L., Xu, D., O'Connor, D. P., Jansson, M. & La Thangue, N. B. A new effector pathway links ATM kinase with the DNA damage response. Nature Cell Biol. 6, 968-976 (2004).
9. Bedford, M. T. & Richard, S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18, 263-272 (2005).
10. Branscombe, T. L., Frankel, A., Lee, J. H., Cook, J. R., Yang, Z., Pestka, S. & Clarke, S. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J. Biol. Chem. 276, 32971-32976 (2001).
11. Chene, P. (2001). The role of tetramerization in p53 function. Oncogene 20, 2611-7.
12. Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672 (1999).
13. Meister, G. et al. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr. Biol. 11, 1990-1994 (2001).
14. Pal, S., Vishwanath, S. N., Erdjument-Bromage, H., Tempst, P. & Sif, S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell Biol. 24, 9630-9645 (2004).
15. Rho, J. et al. PRMT5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family. J. Biol. Chem. 276, 11393-401 (2001).
16. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998).
17. Meek, D. W. The p53 response to DNA damage. DNA Repair 3, 1049-1056 (2004).
18. Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058 (2000).
19. Vousden, K. H. Apoptosis. p53 and PUMA: A deadly duo. Science 309, 1685-1686 (2005).
20. Fortin, A. et al. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J. Cell Biol. 155, 207-216 (2001).
21. Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
22. Oda, K. et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102, 849-862 (2000).
23. Nishi, K. et al. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269, 6320-6324 (1994).
24. Qian, H., Wang, T., Naumovski, L., Lopez, C. D. & Brachmann, R. K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21, 7901-7911 (2002).
25. Zhao, R. et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14, 981-993 (2000).
26. Hollstein, M. et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994).
27. Davison, T. S., Yin, P., Nie, E., Kay, C. & Arrowsmith, C. H. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome. Oncogene 17, 651-656 (1998).
28. Lomax, M. E., Barnes, D. M., Hupp, T. R., Picksley, S. M. & Camplejohn, R. S. Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members. Oncogene 17, 643-649 (1998).
29. Kawaguchi, T. et al. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library. Oncogene 24, 6976-6981 (2005).
30. Stevens, C., Smith, L. & La Thangue, N. B. Chk2 activates E2F-1 in response to DNA damage. Nature Cell Biol. 5, 401-409 (2003).